会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明公开
    • ANTICANCER AGENT
    • KREBSMITTEL
    • EP1724265A4
    • 2008-11-26
    • EP04772348
    • 2004-08-27
    • WAN STATION CO LTD
    • ONO NOBUFUMI
    • C07D257/10A61K31/395A61P35/00
    • C07D257/10A61K31/395
    • A new anticancer agent which is less apt to be discharged from cancer cells and is suitable for use in a local treatment of cancer cells. The anticancer agent contains a catenane compound represented by the chemical formula (I): [Chemical formula 1] (I) as an active ingredient. This catenane compound is a kind of compound called amide type [2]catenane, and consists of two molecular rings fitted into each other like a chain and not linked to each other by covalent bonding. Because of this, the molecular shape is apt to change and incorporation through a receptor is relatively difficult. However, once the compound is introduced into cancer cells, cancer cell proliferation is inhibited.
    • 一种新型的抗癌剂,不易从癌细胞中排出,适用于局部治疗癌细胞。 抗癌剂含有由化学式(I)表示的c系化合物:[化学式1](I)作为有效成分。 该c化合物是一种称为酰胺型[2] c化合物的化合物,由两个彼此嵌合的分子环组成,并且不通过共价键相互连接。 因此,分子形状易于改变,并且通过受体结合相对困难。 但是,一旦将化合物引入癌细胞中,癌细胞增殖受到抑制。